Skip to main content
Premium Trial:

Request an Annual Quote

David Evans, Geoff Ginsburg, Josh LaBaer, Ray Stoll, Anthony Recupero, Karen Gibson, Nicolas Barthelemy


Woburn, Mass.-based GeneXP this week named a seven-person scientific advisory board including: David Evans, head of drug discovery for the Translational Genomics Research Institute; Geoff Ginsburg, vice president, molecular medicine and research strategy, Millennium; Glenn Hoke, president and chief science officer, Dyad Pharmaceuticals and former vice president of research and development, Gene Logic; Josh LaBaer, director, Harvard Institute of Proteomics, Harvard Medical School; John Quackenbush, investigator, The Institute for Genomic Research; and Ray Stoll, former director of toxicology and safety assessment, Boehringer Ingelheim.

Anthony Recupero has joined MaxCyte, a therapeutic gene transfer company based in Rockville, Md., as vice president for business development. He was previously senior director for business development at Gene Logic.

Karen Gibson has become senior vice president of information technology and chief information officer, and Nicolas Barthelemy has become senior vice president of global operations of Invitrogen. Gibson was previously vice president of global e-business and chief information officer at General Electric’s Medical Systems Information Technologies division. She holds an MBA from Ohio University and a BS in computer technology from Purdue. Barthelemy joins Invitrogen from Biogen, where he was vice president of manufacturing and general manager of the company’s Research Triangle Park site. He holds a degree in mathematics, physics, and chemistry from the Ecole Superieure de Physiques et Chimie Industrielles in France, and a master’s of science in chemical engineering from the University of California at Berkeley.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.